Fixed drug eruption to sitagliptin

Fixed drug eruption is a common adverse effect seen with various drugs notably antibiotics, antiepileptics and non-steroidal anti-inflammatory drugs. Herein we report a case of Sitagliptin induced fixed drug eruption in a 46 year old female who developed circumscribed, erythematous macules all over...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Mrinal, Gupta, Anish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376512/
https://www.ncbi.nlm.nih.gov/pubmed/25821748
http://dx.doi.org/10.1186/s40200-015-0145-2
_version_ 1782363748497883136
author Gupta, Mrinal
Gupta, Anish
author_facet Gupta, Mrinal
Gupta, Anish
author_sort Gupta, Mrinal
collection PubMed
description Fixed drug eruption is a common adverse effect seen with various drugs notably antibiotics, antiepileptics and non-steroidal anti-inflammatory drugs. Herein we report a case of Sitagliptin induced fixed drug eruption in a 46 year old female who developed circumscribed, erythematous macules all over the body within one week of initiation of Sitagliptin. The lesions resolved with residual hyperpigmentation on cessation of the drug. The diagnosis was confirmed by an oral provocation test which led to a reactivation of the lesions. To the best of our knowledge, this is the first case of fixed drug eruption to Sitagliptin reported in the literature.
format Online
Article
Text
id pubmed-4376512
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43765122015-03-28 Fixed drug eruption to sitagliptin Gupta, Mrinal Gupta, Anish J Diabetes Metab Disord Case Report Fixed drug eruption is a common adverse effect seen with various drugs notably antibiotics, antiepileptics and non-steroidal anti-inflammatory drugs. Herein we report a case of Sitagliptin induced fixed drug eruption in a 46 year old female who developed circumscribed, erythematous macules all over the body within one week of initiation of Sitagliptin. The lesions resolved with residual hyperpigmentation on cessation of the drug. The diagnosis was confirmed by an oral provocation test which led to a reactivation of the lesions. To the best of our knowledge, this is the first case of fixed drug eruption to Sitagliptin reported in the literature. BioMed Central 2015-03-25 /pmc/articles/PMC4376512/ /pubmed/25821748 http://dx.doi.org/10.1186/s40200-015-0145-2 Text en © Gupta and Gupta; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Gupta, Mrinal
Gupta, Anish
Fixed drug eruption to sitagliptin
title Fixed drug eruption to sitagliptin
title_full Fixed drug eruption to sitagliptin
title_fullStr Fixed drug eruption to sitagliptin
title_full_unstemmed Fixed drug eruption to sitagliptin
title_short Fixed drug eruption to sitagliptin
title_sort fixed drug eruption to sitagliptin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376512/
https://www.ncbi.nlm.nih.gov/pubmed/25821748
http://dx.doi.org/10.1186/s40200-015-0145-2
work_keys_str_mv AT guptamrinal fixeddrugeruptiontositagliptin
AT guptaanish fixeddrugeruptiontositagliptin

Ejemplares similares